Diagnostic News and Research

RSS

Researchers discover new diagnostic test for prostate cancer

Researchers in England say they have discovered a set of biomarkers that can distinguish prostate cancer from benign prostate disease and healthy tissue with 90 percent accuracy.

From Oxford Gene Technology 29 Sep 2010

Past malpractice claims help doctors avoid future mistakes

Medical providers are using past malpractice cases to help avoid future mistakes, The Wall Street Journal reports.

29 Sep 2010

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer, pancreatic and mesothelioma.

29 Sep 2010

Escalon Medical reports 0.2% increase in product revenue for fiscal year 2010

Escalon Medical Corp. today announced results for its fiscal year ended June 30, 2010. Consolidated product revenue from continued operations for fiscal 2010 increased approximately 0.2% to $30,657,000, compared with $30,600,000 in the prior fiscal year.

29 Sep 2010

NCI awards A&G $1.2M Phase II SBIR grant for development of breast cancer drug candidate

A&G Pharmaceutical announced today that it has received $1.2 million in Phase II Small Business Innovation Research (SBIR) funding from the National Cancer Institute (NCI) for the program, "Novel Targeted Therapy for Breast Cancer," focused on the development of a neutralizing therapeutic antibody against a novel cancer-associated protein, GP88.

29 Sep 2010

$IOF report reveals poor state of post-fracture care in Russian Federation$

IOF report reveals poor state of post-fracture care in Russian Federation

Preliminary findings from an upcoming new report by the International Osteoporosis Foundation (IOF) show alarming projections and reveal the poor state of post-fracture care in the Russian Federation and many other countries in the region. The findings were announced today at a press conference in St. Petersburg at the IOF Summit of Eastern European and Central Asian Osteoporosis Patient Societies.

28 Sep 2010

Health Council of Canada releases report on how physicians' decisions affect healthcare services in Canada

A report released today by the Health Council of Canada, Decisions, Decisions: Family Doctors as Gatekeepers to Prescription Drugs and Diagnostic Imaging in Canada, calls for better management of prescription drugs and diagnostic imaging services in this country.

28 Sep 2010

GATC Biotech to apply Illumina's HiSeq 2000 for human genome analysis

Within the next four years GATC Biotech plans to analyse 100,000 human genomes in particular for the pharmaceutical and diagnostic industry as well as for academic research. This will be realised by applying Illumina's HiSeq 2000 as well as GATC Biotech's latest acquisition, the single molecule sequencing platform PacBio RS.

28 Sep 2010

GenMark’s eSensor technology selected for Warfarin clinical study

GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that their eSensor Warfarin Sensitivity Test has been selected for use in a new pivotal Warfarin clinical study the WARFARIN Trial.

28 Sep 2010

HCC report supports implementation of medical imaging guidelines for physicians

The Canadian Association of Radiologists (CAR) recently contributed to a report produced by the Health Council of Canada (HCC) entitled “Decisions, Decisions: Family Doctors as Gatekeepers in the Use of Prescription Drugs and Diagnostic Imaging in Canada.” This report, which was released today, supports one of the CAR’s main objectives: to implement medical imaging guidelines at a national level to guide physicians in selecting the most effective diagnostic imaging exam the first time.

28 Sep 2010

Government of Canada invests to speed up implementation of EMR systems

Canadian physicians and nurse practitioners will benefit from a $500 million investment made by the Government of Canada in Budget 2010, announced Richard Alvarez, President and CEO of Canada Health Infoway (Infoway).

28 Sep 2010

Radiologists can predict cardiovascular disease well using CT: Study

Using incidental findings from routine diagnostic CT, radiologists may be better able to identify people at high risk for cardiovascular disease, according to a new study appearing online and in the November issue of Radiology.

28 Sep 2010

OpGen completes Series B equity financing

OpGen, Inc., a commercial phase genomics company, today announced the successful completion of a $17 million Series B equity financing.

28 Sep 2010

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute of Medical Research (Sydney, Australia) today announced that they have entered into a license agreement in relation to novel biomarkers discovered by scientists at the Garvan Institute. Under the terms of the agreement, Clinical Genomics obtains worldwide exclusive rights to the Garvan's proprietary cancer associated methylation DNA biomarkers for the diagnosis and or treatment of colorectal cancer.

28 Sep 2010

Guided Therapeutics files PMA for LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it filed its completed premarket approval application (PMA) for the LightTouch Cervical Scanner with the U.S. Food and Drug Administration (FDA) for patients at risk for cervical cancer.

28 Sep 2010

UGA researcher receives NIH award for high-risk, high-reward carbohydrate research

The National Institutes of Health has awarded a prestigious EUREKA award to Robert Woods, a professor at the University of Georgia Complex Carbohydrate Research Center, to develop a new method for understanding how antibodies interact with large molecules known as glycans that are a major component of all cell surfaces.

27 Sep 2010

Researchers identify cellular/molecular defect in T cell regulatory pathway

Researchers at Columbia University Medical Center have identified a defect in the T cell regulatory pathway which normally controls autoreactive T cells that attack the body's own tissues and organs. A majority of people with Type 1 diabetes who were tested in the study were found to have the newly-identified cellular/molecular defect, and the researchers were able to successfully correct the defect in-vitro.

27 Sep 2010